This is the authors' abstract. We don't add key points for this paper.
Chronic kidney disease is characterized by progressive renal fibrosis, yet effective anti-fibrotic therapies remain limited. Cellular Communication Network Factor 1 (CCN1) is a matricellular protein that regulates cell migration, proliferation, and extracellular matrix production. We previously demonstrated that proximal tubule-derived CCN1 promotes fibroblast recruitment and fibrosis during acute kidney injury; however, its role during progressive renal fibrosis remains unclear. Here, we investigated the cell source-specific functions of CCN1 using a unilateral ureteral obstruction (UUO) model and proximal tubule/fibroblast-specific CCN1-deficient mice. Proximal tubule-specific deletion of CCN1 did not alter renal fibrosis after UUO, whereas fibroblast-specific deletion unexpectedly exacerbated fibrosis and increased the expression of fibrotic markers. In vitro, CRISPR-Cas9-mediated CCN1 deletion in NRK49F fibroblasts markedly impaired cell migration and proliferation and increased cell size. RNA sequencing revealed downregulation of chemotaxis, PI3K-Akt, MAPK, focal adhesion, and TGF-β signaling pathways in CCN1 deleted NRK49F. Consistent with these findings, CCN1 deficiency reduced AKT and ERK phosphorylation and attenuated TGF-β-induced SMAD activation and expression of Acta2 and Ccn2 . In contrast, TGF-β-induced expression of extracellular matrix genes, including Col1a1 , and Fn1 , was enhanced by CCN1 deficiency, suggesting activation of alternative, SMAD-independent mechanisms. These findings indicate that fibroblast-derived CCN1 is not simply a pro-fibrotic factor but contributes to fibroblast integrity by maintaining their migratory and proliferative properties while modulating TGF-β signaling and extracellular matrix production. The biological effects of CCN1 are therefore highly dependent on its cellular source and the context of kidney injury.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Sawai et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: